1. Home
  2. IQV vs TRI Comparison

IQV vs TRI Comparison

Compare IQV & TRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$166.19

Market Cap

41.3B

Sector

Health Care

ML Signal

HOLD

Logo Thomson Reuters Corp

TRI

Thomson Reuters Corp

HOLD

Current Price

$83.23

Market Cap

37.0B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IQV
TRI
Founded
1982
1851
Country
United States
Canada
Employees
93000
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.3B
37.0B
IPO Year
2013
2002

Fundamental Metrics

Financial Performance
Metric
IQV
TRI
Price
$166.19
$83.23
Analyst Decision
Buy
Buy
Analyst Count
15
11
Target Price
$233.33
$164.55
AVG Volume (30 Days)
2.6M
2.9M
Earning Date
05-08-2026
01-01-0001
Dividend Yield
N/A
2.87%
EPS Growth
4.67
N/A
EPS
7.84
N/A
Revenue
$9,739,000,000.00
N/A
Revenue This Year
$6.77
$8.86
Revenue Next Year
$5.91
$7.86
P/E Ratio
$21.59
$25.72
Revenue Growth
41.60
N/A
52 Week Low
$134.65
$81.91
52 Week High
$247.05
$218.40

Technical Indicators

Market Signals
Indicator
IQV
TRI
Relative Strength Index (RSI) 26.66 23.15
Support Level $161.94 $81.91
Resistance Level $171.14 $86.53
Average True Range (ATR) 10.96 5.53
MACD -2.88 -0.13
Stochastic Oscillator 15.47 11.54

Price Performance

Historical Comparison
IQV
TRI

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About TRI Thomson Reuters Corp

Thomson Reuters is a leading global provider of business information services, delivering trusted data, technology, and expertise to professionals across legal, tax, accounting, risk, compliance, and the news and media sectors. Headquartered in Toronto, Canada, the company combines deep domain knowledge with data and software solutions to help clients make informed decisions, manage complexity, and drive efficiency. Thomson Reuters serves legal and accounting/tax professionals, corporations, and governments worldwide, but around 75% of revenue is generated in the US. The company is known for flagship products such as Westlaw, UltraTax CS, and Reuters News.

Share on Social Networks: